A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa.

@article{Coleman2004ATA,
  title={A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa.},
  author={Paul Gerard Coleman and Chantal France Morel and Sam Shillcutt and Catherine A. Goodman and Anne J. Mills},
  journal={The American journal of tropical medicine and hygiene},
  year={2004},
  volume={71 2 Suppl},
  pages={196-204}
}
Artemisinin-based combination therapies (ACTs) are generally regarded as vital in addressing the growing problem posed by the development of antimalarial resistance across sub-Saharan Africa. However, the costs of the new ACTs are likely to be significantly higher than current therapies. Therefore, it is important to examine formally the cost-effectiveness of the more effective yet more expensive ACTs before advocating a switch in policy. Importantly, any such economic evaluation must consider… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

ACTs: Availability and Prices. Geneva: World Health Organization. Presentation at Roll Back Malaria Partners Meeting, October 1. COLEMAN AND OTHERS

JM Kindermans
2002

The evolution of drug-resistant malaria: the role of drug elimination half-life.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences • 2002
View 1 Excerpt

Artemisinin derivatives for treating uncomplicated malaria.

The Cochrane database of systematic reviews • 2000
View 1 Excerpt

Economic Analysis of Malaria Control in Sub-Saharan Africa

CA Goodman, PG Coleman, A Mills
Geneva: World Health Organization. Global Forum for Health Research • 2000

Similar Papers

Loading similar papers…